Leukemia, Promyelocytic, Acute: all 110 studies
Page 2 of 2. Open to participants first (17), then studies with results posted, then the rest; newest registration first within each.
- Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaTerminatedNCT00042796Phase 1
- Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic LeukemiaWithdrawnNCT00030355Phase 1/2
- Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic LeukemiaCompletedNCT00016159Phase 2
- Arsenic Trioxide in Treating Patients With Refractory or Recurrent Acute Promyelocytic LeukemiaCompletedNCT00008697Phase 1/2
- BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid LeukemiaCompletedNCT00006213Phase 1
- PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic SyndromeCompletedNCT00005064Phase 1
- Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic LeukemiaCompletedNCT00003934Phase 3
- Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic LeukemiaActive, not recruitingNCT00003861
- Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic LeukemiaStatus unknownNCT00002701Phase 3
- Monoclonal Antibody Therapy and Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia in RemissionCompletedNCT00002609Phase 2